Plain-English translation of NCT06553235 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smartphone app called Hvil® that teaches cognitive behavioral therapy for insomnia (a proven talk-based approach) can help breast cancer survivors who have finished treatment and are struggling with sleep problems and trouble concentrating or remembering things. The study will compare this app-based sleep therapy to a simpler app that just teaches basic sleep habits. Researchers will look at whether the more intensive therapy helps people sleep better and think more clearly.
Many breast cancer survivors experience ongoing problems with sleep and concentration even after their cancer treatment ends, and these problems can significantly affect their quality of life. This trial exists to see if a convenient app-based therapy—which works well for insomnia in other groups—can help these survivors regain better sleep and clearer thinking.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either the full sleep therapy app or the basic sleep habits education app, and you'll use your assigned app for 6 to 9 weeks. You'll have assessments at the start, after the program ends, and again 6 months later—these include computer-based thinking tests, questionnaires about your sleep, and possibly brain imaging and blood work. The study is designed to fit into your life at home through the app on your smartphone.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Denmark